.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Healthtrust
Farmers Insurance
Cipla
McKinsey
Teva
Merck
Novartis
Fuji

Generated: September 26, 2017

DrugPatentWatch Database Preview

IMODIUM MULTI-SYMPTOM RELIEF Drug Profile

« Back to Dashboard

Which patents cover Imodium Multi-symptom Relief, and what generic Imodium Multi-symptom Relief alternatives are available?

Imodium Multi-symptom Relief is a drug marketed by J And J Consumer Inc and is included in two NDAs. There is one patent protecting this drug.

This drug has twenty patent family members in seventeen countries.

The generic ingredient in IMODIUM MULTI-SYMPTOM RELIEF is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.

Summary for Tradename: IMODIUM MULTI-SYMPTOM RELIEF

Patents:1
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Clinical Trials: see list13,564
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IMODIUM MULTI-SYMPTOM RELIEF at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc
IMODIUM MULTI-SYMPTOM RELIEF
loperamide hydrochloride; simethicone
TABLET, CHEWABLE;ORAL020606-001Jun 26, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe
J And J Consumer Inc
IMODIUM MULTI-SYMPTOM RELIEF
loperamide hydrochloride; simethicone
TABLET;ORAL021140-001Nov 30, 2000OTCYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: IMODIUM MULTI-SYMPTOM RELIEF

International Patent Family for Tradename: IMODIUM MULTI-SYMPTOM RELIEF

Country Document Number Estimated Expiration
Hungary9801615► Subscribe
Czech Republic9802221► Subscribe
Brazil9802487► Subscribe
JapanH1192387► Subscribe
Argentina013227► Subscribe
New Zealand330915► Subscribe
Czech Republic294084► Subscribe
Denmark0891776► Subscribe
European Patent Office0891776► Subscribe
Australia727271► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: IMODIUM MULTI-SYMPTOM RELIEF

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB98/013United Kingdom► SubscribePRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
McKesson
Covington
Chinese Patent Office
Daiichi Sankyo
US Army
Merck
Dow
Queensland Health
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot